ID: ALA4092501

Max Phase: Preclinical

Molecular Formula: C20H23N5

Molecular Weight: 333.44

Molecule Type: Small molecule

Representations

Canonical SMILES:  CN(C)CCNCCn1c2ccccc2c2nc3ccccc3nc21

Standard InChI:  InChI=1S/C20H23N5/c1-24(2)13-11-21-12-14-25-18-10-6-3-7-15(18)19-20(25)23-17-9-5-4-8-16(17)22-19/h3-10,21H,11-14H2,1-2H3

Standard InChI Key:  PEKKLDGFPWCPEY-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 333.44

Molecular Weight (Monoisotopic): 333.1953

AlogP: 2.89

#Rotatable Bonds: 6

Polar Surface Area: 45.98

Molecular Species: BASE

HBA: 5

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 9.85

CX LogP: 3.05

CX LogD: 0.64

Aromatic Rings: 4

Heavy Atoms: 25

QED Weighted: 0.55

Np Likeness Score: -1.25

References

1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A..  (2017)  Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents.,  27  (16): [PMID:28666733] [10.1016/j.bmcl.2017.06.035]

Source

Source(1):

• Scientific Literature